SCHEMBL3743365

SCHEMBL3743365

Cc1cccc(C(C)C(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 2/20 0.43
P2RX7 Q99572 1/20 0.41
PTGS2 P35354 3/20 0.40
CCR1 P32246 1/20 0.40
CCR8 P51685 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
GBA1 P04062 1/20 0.40
KMT2A Q03164 1/20 0.40
PTGS1 P23219 3/20 0.39
MAPT P10636 2/20 0.39
CXCR1 P25024 2/20 0.39
CXCR2 P25025 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GRM5 P41594 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27605894 0.86 RAB9A (0.48) RECQLHTTRAB9AP2RX7CCR1
SCHEMBL14593498 0.83 HTT (0.44) RECQLHTTRAB9AP2RX7CCR1
SCHEMBL3638163 0.82 HTT (0.50) RECQLHTTRAB9AP2RX7CCR1
SCHEMBL17921346 0.81 HTT (0.49) RECQLHTTRAB9AP2RX7CCR1
SCHEMBL17827993 0.80 RAB9A (0.43) RECQLHTTRAB9AP2RX7PTGS2
SCHEMBL24031283 0.79 PTGS2 (0.39) RECQLPTGS2PTGS1MAPTCXCR1
SCHEMBL13089880 0.79 AKR1C3 (0.39) RECQLPTGS2MEN1KMT2APTGS1
SCHEMBL7797424 0.79 XIAP (0.46) RECQLPTGS2PTGS1MAPTCXCR1
SCHEMBL25260074 0.78 KDM4E (0.41) RECQLPTGS2PTGS1MAPTCXCR1
Hydrochloric Acid SCHEMBL2182637 0.78 AKR1C3 (0.38) RECQLPTGS2MEN1KMT2APTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023226965-A1 ROCK INHIBITORS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2023-11-30 WO disclosed
WO-2011095997-A1 BENZAMIDE COMPOUNDS AS GLUCOKINASE ACTIVATORS AND THEIR PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-08-11 WO disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R RECQL 4756/4885HTT 316/4885RAB9A 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.